As medical researchers and clinicians, we are concerned about the proposed reductions in funding for the U.S. National ...

Journal of Nuclear Medicine February 2025, jnumed.124.268967; DOI: https://doi.org/10.2967/jnumed.124.268967 Cancer therapy has advanced with molecularly targeted ...

EDA-FN is abundant in BC, with high EDA-FN expression associated with poor overall survival (15). Hormone receptor- and human epidermal growth factor receptor 2–negative BCs, collectively known as ...

Single-domain antibody (sdAb) is among the most promising vectors for developing molecular imaging tracers. Several sdAb tracers targeting human epidermal growth factor receptor 2 or programmed death ...

Multisystemic inflammation might be a key pathophysiologic mechanism in post–coronavirus disease 2019 (post-COVID) syndrome. N,N- diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)5,7dimethylpyrazolo[1,5a] ...

Prostate-specific membrane antigen (PSMA) PET is a well-established imaging tool for the evaluation of primary and recurrent prostate cancer (PCa). 177 Lu PSMA-targeted radiopharmaceutical therapy ...

This review explores the role of PET in imaging immune activation, particularly in oncology. 18 F-FDG is widely used for assessing treatment response to immunotherapies and can demonstrate unique ...

Journal of Nuclear Medicine April 2025, jnumed.124.269203; DOI: https://doi.org/10.2967/jnumed.124.269203 ...

TO THE EDITOR: Radiopharmaceuticals for PET imaging are regulated as drugs by the U.S. Food and Drug Administration (FDA) through several offices within the Center for Drug Evaluation and Research, ...

The field of nuclear medicine is going through a renaissance with significant investment by a biotechnology and pharmaceutical industry finally recognizing the benefits of the theranostic paradigm.

The study of the human phenome is essential for understanding the complexities of wellness and disease and their transitions, with molecular imaging being a vital tool in this exploration. Molecular ...

The Highlights Lecture, presented at the closing session of each SNMMI Annual Meeting, was originated and presented for more than 30 y by Henry N. Wagner, Jr., MD. Beginning in 2010, the duties of ...